Exceptional track record across multiple clinical development programs for depression, three of which have resulted in regulatory approvalsAppointment strengthens confidence in clinical readiness and ...
DUBLIN--(BUSINESS WIRE)--The "US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026" report has been added to ResearchAndMarkets.com's offering. The complete research report is divided ...
Always at the forefront of innovation, CD Formulation continues to be a trustworthy CRO partner for pharmaceutical companies around the world. With unstopping efforts to expand its service portfolio, ...
Collaboration aims to leverage Polyrizon’s advanced proprietary intranasal delivery platform to support clinical development of Clearmind’s drug candidate proprietary MEAI Raanana, Israel, Feb. 06, ...
Collaborative partnerships can foster success in formulation development projects. The formulation development outsourcing market is expected to grow at a compound annual rate of 7.2% between 2021 and ...
RAANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ) announced on Thursday it has entered into a development agreement with Clearmind Medicine Inc. (NASDAQ:CMND) to create a proprietary intranasal ...
February 18, 2026 8:00 AM EST | Source: Marvel Biosciences Corp. Calgary, Alberta--(Newsfile Corp. - February 18, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), is pleased to announce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results